Please assess the completion status of the following clinical trial:

Trial Title: Effect of Epinephrine on Systemic Absorption of Mepivacaine in Uremic Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patient acceptance of regional anaesthesia~Exclusion Criteria:~* peripheral arteriosclerosis~* diabetes mellitus~* bleeding disorder~* infection at the puncture site~* allergy to mepivacaine~* pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Plain mepivacaine (Type: ACTIVE_COMPARATOR): None
- Mepivacaine with epinephrine (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).